In hepatocellular carcinoma (HCC), the combination of HIF-1α inhibitors with metabolic modulators such as palmitic acid and L-carnitine has shown potential in inducing apoptosis in hypoxic HCC cells by preventing lipid metabolism reprogramming (138). This evidence concerns the gene HIF1A and hepatocellular carcinoma.